Kangmei Pharma | 600518 - Assets

Stock Price
1.75
Daily Change
-0.08 -4.37%
Monthly
-5.91%
Yearly
-7.89%
Q2 Forecast
1.71

Kangmei Pharma reported CNY13.68B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Genomma Lab Internacional MXN 23.83B 226.23M Dec/2025
Hypermarcas BRL 25.16B 4.34M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Jiangsu Hengrui CNY 69.87B 1.54B Dec/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Sh Fosun Pharma CNY 120.05B 1.93B Dec/2025
Tectonic Therapeutic USD 261.04M 15.96M Dec/2025
Viatris USD 37.19B 727.3M Dec/2025
Wuxi Apptec CNY 103.12B 8.51B Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025